Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host intestinal mucosal surface represents a complex multi-layered system consisting of the intestinal epithelium, the overlying mucus layer, the resident microbiota, and the underlying gut-associated lymphoid tissue (GALT) (Mowat & Agace, 2014, Nature Reviews Immunology). This system serves as a critical interface between the external environment and the host's internal milieu, performing essential functions such as nutrient absorption and acting as a selective barrier against pathogens (Vancamelbeke & Vermeire, 2017, Therapeutic Advances in Gastroenterology). The epithelial cells provide a physical barrier maintained by tight junctions, while specialized immune cells monitor the environment to mount appropriate responses to threats (Okumura & Takeda, 2017, Nature Reviews Immunology). Pathogenic organisms can disrupt this balance, leading to infections or chronic inflammatory states like inflammatory bowel disease (IBD) (Ribet & Cossart, 2015, Microbes and Infection). Therapeutic strategies targeting this system often focus on specific molecular components within it, such as integrins involved in immune cell trafficking or cytokines that drive inflammation (Danese, 2012, Gut). Understanding the interplay between these various components is vital for developing treatments that restore mucosal homeostasis and barrier integrity.
Drugs targeting this system typically work by modulating immune cell recruitment, neutralizing inflammatory mediators, or altering the microbial environment to restore barrier function and homeostasis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal mucosal surfaces, epithelial cells, pathogens, and immune cells.